Press release
Immunology Drugs Market Key Players Analysis - Eli Lilly, AbbVie Inc, F.Hoffmann-La roche Ltd, Amgen Inc, Pfizer.
Immunology Drugs Market
The Immunology Drugs Market Size is estimated to grow at a CAGR of 10.5 % during the forecast period for 2025-2034.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1328
Immunology drugs are targeted pharmaceutical agents developed to modulate immune system function by either enhancing or suppressing immune responses. These therapies play a critical role in the management and prevention of autoimmune and immunological disorders, as well as in the treatment of select infectious diseases. The global immunology drugs market is witnessing robust expansion, fueled by growing awareness of immune-related conditions across both developed and emerging markets and a rising prevalence of such disorders, often attributed to environmental triggers.
A large segment of the global population is affected by autoimmune diseases, which are increasingly linked to environmental factors such as infections, psychological stress, dietary habits, gut microbiota imbalances, and exposure to toxic substances. This rising burden has prompted increased investment in research and development from key market participants. Heightened public and clinical awareness, combined with a growing pipeline of innovative immunological therapies, is expected to drive market growth over the forecast horizon. Notably, clinical advancements suggest that immunology drugs can deliver durable therapeutic responses, particularly in oncology, by enhancing the immune system's ability to detect and eradicate cancer cells beyond the initial reduction of tumor mass.
Nonetheless, several challenges could temper the pace of market expansion. Chief among these are the high production costs and the risk of adverse effects associated with these therapies. Biologic drugs, which represent a significant portion of the immunology segment, are particularly costly due to their complex manufacturing processes and the extensive resources required for research, clinical trials, and regulatory approvals.
From a regional perspective, North America is expected to dominate the global immunology drugs market, with the United States leading due to its advanced healthcare infrastructure, high incidence of chronic immune-related conditions, and well-established diagnostic and therapeutic capabilities. Increased demand for effective treatment options and greater public health engagement are likely to sustain regional market growth throughout the forecast period.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-03
Prominent players in the immunology drugs market are Eli Lilly Company, AbbVie Inc, F.Hoffmann-La roche Ltd, Amgen Inc, Pfizer, Novartis, Astellas, Alector, ImmuNext, Merck sharp & Dohme Corp., UCB SA, and other prominent players.
Key Developments In The Market:
• In Jun 2022, FDA authorised RIABNITM (rituximab-arrx) for use in individuals with moderately to severely active rheumatoid arthritis (RA) who have not responded effectively to one or more TNF antagonist treatments. Amgen has eleven biosimilars under development, including cancer and chronic inflammatory disease therapies.
• In May 2022, AbbVie and Cugene announced a worldwide licence option agreement for CUG252, a possible best-in-class Treg-selective IL-2 mutein, and additional new IL-2 muteins for the treatment of autoimmune and inflammatory disorders. Cugene will receive an upfront payment of $48.5 million, development and regulatory milestone payments, and a licence option exercise payment if AbbVie exercises the option.
• In Sept 2021, Lycia Therapeutics and Eli Lilly and Company announced a multiyear research collaboration and licence agreement to explore, develop, and commercialise new targeted pharmaceutical candidates. The companies will utilise Lycia Therapeutics' LYTAC (lysosomal targeting chimaera) platform to identify and develop drug candidates for up to five targets in Eli Lilly & Company's therapeutic areas, such as immunology and pain.
• In July 2020, The Janssen Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) had approved an expanded indication for STELARA (ustekinumab) as a treatment for young patients (ages 6 to 11) who struggle with the skin lesions or plaques connected to moderate to severe plaque psoriasis (PsO). STELARA targets interleukin (IL)-12 and IL-23, two cytokines thought to be crucial in regulating the excessive inflammatory response in various autoimmune diseases, including PsO.
• In May 2020, AbbVie announced that it had completed its purchase of Allergan plc after receiving regulatory approval from all government bodies needed by the deal agreement. The deal considerably broadens and diversifies AbbVie's income stream and strengthens the company's already-established leadership positions in Immunology Drugs with Humira, hematologic oncology with Imbruvica, and Rinvoq.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1328
Global Immunology Drugs Market, by by Drug Class, 2022-2030 (Value US$ Bn)
• Monoclonal antibody
• Fusion Proteins
• Immunosuppressant
• Polyclonal antibody
• Other Drug Class
Global Immunology Drugs Market, by Distribution Channel, 2022-2030 (Value US$ Bn)
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other Distribution Channel
Global Immunology Drugs Market, by Disease Indications, 2022-2030 (Value US$ Bn)
Rheumatoid Arthritis
• Psoriatic Arthritis
• Plaque Psoriasis
• Ankylosing Spondylitis
• Inflammatory Bowel disease
• Other disease Indication
Global Immunology Drugs Market, by Region, 2022-2030 (Value US$ Bn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Immunology Drugs Market, by Country, 2022-2030 (Value US$ Bn)
• U.S.
• Canada
Europe Immunology Drugs Market, by Country, 2022-2030 (Value US$ Bn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Immunology Drugs Market, by Country, 2022-2030 (Value US$ Bn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Immunology Drugs Market, by Country, 2022-2030 (Value US$ Bn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Immunology Drugs Market, by Country, 2022-2030 (Value US$ Bn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Read Overview Report- https://www.insightaceanalytic.com/report/global-immunology-drugs-market/1328
Why should buy this report:
• To receive a comprehensive analysis of the prospects for the pipeline products in the global immunology drugs market
• To receive an industry overview and future trends of the immunology drugs market
• To analyze immunology drugs market drivers and challenges
• To get information on the immunology drugs market size (Value US$ Bn) forecast to 2030
• To get the information on investments, mergers & acquisitions in the immunology drugs market industry
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immunology Drugs Market Key Players Analysis - Eli Lilly, AbbVie Inc, F.Hoffmann-La roche Ltd, Amgen Inc, Pfizer. here
News-ID: 4107566 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Pathogen or Plant Disease Detection and Monitoring Market Top Companies Study - …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Pathogen or Plant Disease Detection and Monitoring Market - (By Application (Open Field, Controlled Environment), By Product (Diagnostic Kits, Digital Solutions, Laboratory Services)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Pathogen or Plant Disease Detection and Monitoring Market is valued at USD 2.02 Bn…
Agriscience Hyperspectral Imaging Market Growth Fueled by Crop Monitoring and Di …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Agriscience Hyperspectral Imaging (HSI) Market - (By Type (Visible Light + Near Infrared, Short Infrared Wave), By Application (Agricultural Robots/ Agricultural Vehicles, Drones)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Agriscience Hyperspectral Imaging (HSI) Market is valued at US$ 14.04 Mn in 2022, and…
Integrated Recirculating Aquaculture System Market Report Covers Closed Type and …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Integrated Recirculating Aquaculture System (RAS) Market - (By Grade (Closed Type, Semi-Closed Type), By Application (Outdoor System, Indoor System)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Integrated Recirculating Aquaculture System (RAS) Market is valued at USD 5.2 Billion in 2024, and it is expected…
Digital Agriculture Market Outlook Highlights Growth in Precision Farming and Sm …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital Agriculture Market Size, Share & Trends Analysis Report By Offerings (Advisory Services, Precision Agriculture & Farm Management, Quality Management & Traceability, Digital Procurement, Agri E-Commerce, And Financial Services), Technology (Peripheral, Core), Operation (Farming & Feeding, Monitoring & Scouting, Marketing & Demand Generation) Type (Hardware, Software, Services), Region, Market Outlook And Industry Analysis 2034"
The Global…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
